Back to search

Netherlands· NL-976233f348a9

Livsane Hooikoortstabletten Cetirizine diHCl 10 mg, filmomhulde tabletten

A cetirizine product containing cetirizinedihydrochloride, registered in Netherlands by Teva Nederland B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC R06AE07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLivsane Hooikoortstabletten Cetirizin…ATCR06AE07REGISTER NO.NL-976233f348a9PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Cetirizine is registered in 16 of 19 countries.

Countries holding a registration under ATC R06AE07 (cetirizine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Cetirizine · ATC R06AE07

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cetirizine costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.20 in Italy to $0.79 in Switzerland — a ×3.8 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Cetirizine · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.79
  • IT Italy$0.20
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CETIRIZINEDIHYDROCHLORIDE
Manufacturer
Teva Nederland B.V.
Country
Netherlands (NL)
ATC code
R06AE07
ATC class
Cetirizine
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    124832=111430

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

670 interactions on record for cetirizine.

Graded by severity as the source publishes them — 264 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cetirizine · interactions on record

670 records

  • 264 moderate
  • 3 minor
  • 403 info

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • DimenhydrinatA04AB02moderate
  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1aad1d82-4273-483e-a0e4-0742db656f93
GET /v1/drugs/1aad1d82-4273-483e-a0e4-0742db656f93?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h124832_smpc.pdf",
  "strength": null,
  "atc_label": "Cetirizine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg124832",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE (E 464)",
    "LACTOSE 1-WATER",
    "MACROGOL 400",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "CETIRIZINEDIHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h124832.pdf",
  "authorised_at": "2019/05/09",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend apotheek of drogist$SEMICOLON$ Algemene verkoop [conform voorwaarden CBG AV-lijst d.d. 22 oktober 2020]",
  "registration_number": "124832=111430",
  "additional_monitoring": "N"
}

See everything about cetirizine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.